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with these procedures has extended their use to patients
with extensive tissue loss, when bypass grafting is
accompanied with free tissue transfer to achieve foot sal-
vage.15 Some authors, however, have expressed concern
over the effectiveness of inframalleolar reconstruction in
patients with end-stage renal disease (ESRD) and exten-
sive heel gangrene.16
Traditionally, the success of distal bypass grafts has
been judged in terms of graft patency and foot salvage.
Assessments of outcome have frequently ignored long-
term morbidity and mortality, functional result, and the
need for repeat interventions. Prolonged rehabilitation
and low rates of survival with a salvaged functional limb
have been reported after successful infrainguinal recon-
structions.17 Factors affecting long-term survival after
pedal bypass grafting are not well known. This study was
undertaken to identify factors affecting long-term clinical
outcome and survival after pedal bypass grafting.
PATIENTS AND METHODS
Clinical data of all patients undergoing pedal bypass
grafts at the Mayo Clinic have been entered in an ongoing
database. We retrospectively analyzed data from 256 con-
secutive patients who underwent 280 pedal bypass grafts
for chronic critical limb ischemia over a 12-year period,
from 1987 to 1998. Data collected included details of pre-
operative clinical status and evaluation, operation, early
and late adjunctive procedures, and ambulatory and sur-
vival status during follow-up. Intraoperative angiograms
of the first 100 patients were reviewed, and the runoff was
Major amputations for critical limb ischemia are still
frequently performed in the United States, despite the
increasing number of surgical reconstructions and endovas-
cular procedures. In the past two decades, the amputation
rate in the United States was 19 to 30 per 100,000 person-
years and approached 140 per 100,000 person-years in
patients older than 85 years.1 Primary amputation carries a
high mortality rate (13%-17%), and successful rehabilita-
tion is limited to two thirds of survivors at best.2-4
Infrainguinal revascularization can be performed, with a
lower mortality rate (3%-4%) and successful limb salvage in
more than three fourths of patients.5,6
Pedal bypass grafting has become an accepted form
of treatment for patients with severe distal disease, limb-
threatening ischemia, and tissue loss, regardless of age
or diabetic status.7,8 The safety and durability of these
procedures with cumulative foot salvage rates of the
order of 80% at 3 to 5 years have been demonstrated in
several series over the past decade.9-14 Increasing success
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Objectives: Assessments of outcome after reconstruction for critical limb ischemia frequently ignore functional result and
long-term morbidity and mortality. This study was undertaken to identify factors affecting long-term clinical outcome
and survival after pedal bypass grafting.
Methods: The clinical data of 256 consecutive patients who underwent pedal bypass grafting for critical limb ischemia
over a 12-year period were retrospectively analyzed.
Results: A total of 174 men and 82 women (median age, 70 years; range, 30-91 years) underwent 280 pedal bypass graft
placements with autologous vein. Seventy-five percent of the patients were diabetic, and 20% had renal insufficiency
(serum creatinine level > 2 mg/dL). The in-hospital mortality rate was 1.6% (4/256). The mean follow-up was 2.7 years
(range, 0.1-10.1 years). Rates of primary and secondary patency, limb salvage, and survival at 5 years were 58%, 71%,
78%, 60%, respectively. A total of 160 limbs (57%) required additional interventions. Nineteen early graft thrombec-
tomies/revisions and nine early amputations were performed. One hundred thirty-eight late interventions included 31
graft salvage procedures, 27 wound debridements, and 34 minor and 42 major amputations. At last follow-up or death,
219 (78%) limbs were being used for ambulation. End-stage renal disease (ESRD) and composite vein grafts predicted
limb loss (P < .001, P < .001, respectively). Overall survival at 5 years was 60%. Survival after amputation was 79%, 53%,
and 26% at 1, 3, and 5 years. Amputation and ESRD predicted higher mortality (P = .014, P = .0001, respectively).
Conclusions: Pedal bypass grafting resulted in good functional limb salvage, but at the expense of multiple interventions
in more than half the cases. ESRD and composite vein graft were associated with poor long-term limb salvage. Amputation
after bypass grafting was associated with significantly worse long-term survival. (J Vasc Surg 2001;33:6-16.)
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graded (1 = patent pedal arch, 2 = incomplete pedal arch,
and 3 = little or no pedal arch).
Postoperative surveillance has been performed with
duplex ultrasound scan since December 1989, and the pro-
tocol includes a return visit at 6 weeks to 3 months and
every 6 months thereafter. For the purpose of this study,
grafts were classified as patent on the basis of clinical exam-
ination of pulses by a physician or duplex scan examination
by a registered vascular technologist. Details of functional
ambulatory status were obtained during a clinic visit (213),
from letters from patient/family member (6)/local physi-
cian (24), or by telephone conversation with the patient
(33). Patients were classified as ambulatory if they were
weight bearing on the index extremity and were using it for
walking or transfer to a wheelchair.
Graft patency, limb salvage, and patient survival were
assessed with the Kaplan-Meier survival method.18
Estimates of patient survival at 1, 3, and 5 years subsequent
to amputation are quoted with the date of amputation as
time zero. Significance tests for long-term survival used the
log-rank test for dichotomous and categoric risk factors.19
Ordinal and continuous risk factors were evaluated for sur-
vival with a Cox proportional hazards model.20 Analysis of
amputation as a risk factor for patient survival also used a
time-dependent Cox proportional hazards model.
Multivariate survival models of graft patency, limb
salvage, and patient survival were constructed with a
stepwise selection procedure. Candidate factors in the
model were those identified univariately as being signifi-
cantly associated with the survival end point. Again, the
Cox proportional hazards model was used for evaluation,
P values, odds ratios, and 95% CIs for the odds ratios
reported. A P value less than .05 was considered to be
statistically significant.
RESULTS
Patients
Between September 15, 1987, and December 21,
1998, 256 patients, 174 (68%) men and 82 (32%) women
(median age, 70 years; range, 30-91 years), underwent
280 pedal bypass grafts. All limbs satisfied criteria for crit-
ical ischemia as proposed by the Reporting Committee of
the Joint Council of the Vascular Societies.21 Two hun-
dred fifty-one (89.6%) limbs had ischemic ulcer or gan-
grene (Chronic Ischemia Category 5), and 29 (10.4%)
limbs had rest pain alone (Category 4). Eighty limbs
(28.6%) had evidence of foot infection or cellulitis.
Risk factors
One hundred ninety-one patients (74.6%) were dia-
betic, and nineteen patients (7.4%) had ESRD (dialysis
[15] and renal transplant [4]). Cardiovascular risk factors
are listed in Table I.
Preoperative evaluation
A total of 279 patients underwent digital subtraction
arteriography; one patient underwent magnetic resonance
angiography. Saphenous vein mapping was performed in
210 limbs. The ankle-brachial index was measured with a
handheld Doppler probe in 243 limbs. In 93 limbs the
vessels were noncompressible. In the remaining 150
limbs, the median ankle-brachial index was 0.44 (range,
0.11-1.29). Transcutaneous oxygen tension was measured
in 247 limbs and was less than 20 mm Hg in 224.
Bypass graft procedure
All but one pedal bypass graft were performed elec-
tively by one of three staff surgeons and a vascular fellow or
general surgery resident. Autogenous vein was used in all
procedures. Nonreversed ipsilateral greater saphenous vein
was the most frequent conduit used (Table II). There were
Table I. Patient demographics
Risk factor No. of patients (%)
Diabetes mellitus 191 (74.6)
Hypertension 172 (67.2)
Smoking 150 (58.6)
Coronary artery disease 132 (51.6)
Hyperlipidemia 105 (41.3)
Cerebrovascular disease 54 (21.1)
Renal insufficiency (serum creatinine level 50 (19.5)
> 2 mg/dL)
ESRD* 19 (7.4)
*Dialysis (n = 15), renal transplant (n = 4).
Table II. Type of conduit
No. (%)
Translocated saphenous vein 183 (65.4)
In situ saphenous vein 35 (12.5)
Reversed saphenous vein 17 (6.1)
Composite vein 45 (16.1)
Bilateral leg veins 18 (40.0)
Ipsilateral leg veins 15 (33.3)
Leg + arm veins 8 (17.8)
Arm veins alone 4 (8.9)
Table III. Sites of proximal anastomosis
No. (%)
Long grafts 130 (46.4)
External iliac 1 (0.4)
Common femoral 51 (18.2)
Superficial femoral 78 (27.9)
Short grafts 150 (53.6)
Popliteal 139 (49.6)
Tibioperoneal trunk 1 (0.4)
Peroneal 2 (0.7)
Posterior tibial 3 (1.1)
Dorsalis pedis 1 (0.4)
Other artery 4 (1.4)
130 bypass grafts classified as “long” grafts and 150 as
“short” grafts (Table III). The dorsalis pedis artery was the
most frequent target vessel (Fig 1). An operating micro-
scope was used to perform the distal anastomosis in more
than half the cases. A bloodless field to perform the distal
anastomosis was obtained with a thigh or calf tourniquet.
Grafts were assessed intraoperatively with completion
angiography, (239) and blood flow measurement was
assessed with an electromagnetic flow probe (270). The
mean flow was 72.53 ± 39.53 mL/min (median, 65.0;
range, 5-220). Patients with flows less than 50 mL/min
received anticoagulation (heparin [180] and warfarin
[114]) postoperatively.
Early results
Mortality. There were four early deaths (3 within 30
days) for an in-hospital mortality rate of 1.6% (30-day
mortality rate, 1.2%). Causes of death included myocardial
infarction, chronic obstructive pulmonary disease with
respiratory failure, acute renal allograft dysfunction with
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Fig 1. Sites of distal anastomosis in 280 pedal bypass grafts.
coagulopathy, and multisystem organ failure, in one
patient each.
Complications. Early complications are listed in
Table IV. They include four transmural and 14 subendo-
cardial myocardial infarctions.
Graft patency. A total of 253 patients with 277 grafts
were alive at 30 days. Nineteen grafts (6.8%) occluded
early, requiring intervention (10 thrombectomy, 9 revi-
sion). Thirty-day primary and secondary patencies were
93.1% and 97.1%, respectively. At discharge, 269 grafts
were patent, and eight were occluded.
Limb salvage. Thirty-day limb salvage was 96.7%
with nine major amputations performed within 30 days:
six after graft failure and three in presence of patent grafts.
Adjunctive procedures. A total of 140 adjunctive proce-
dures were performed within 30 days in 97 limbs (Table V).
Late results
Mortality. The mean follow-up was 2.7 years
(median, 2 years; range, 0.1-10.1 years). During follow-
up, 76 patients (30.2%) died. The 1-, 3-, and 5-year
cumulative survival rates were 87% (95% CI, 82.9-91.7),
76% (95% CI, 69.9-82.2), and 60% (95% CI, 52.5-68.8),
respectively (Fig 2). One-, 3-, and 5-year survival rates in
50 patients subsequent to amputation after pedal bypass
grafting were 79% (95% CI, 67.3-92.3), 53% (95% CI,
36.7-76.2), and 26% (95% CI, 9.3-75.2) (Fig 3).
Complications. There were 23 late wound infections
(8.4%) and one graft infection (0.4%). There was an overall
early and late wound complication rate of 14.9% (Table IV).
Graft patency. During follow-up, 59 (21.5%) grafts
occluded and 23 (8.4%) developed stenoses. At last follow-
up, 186 grafts were primarily patent, 32 secondarily patent,
62 were occluded (35 limbs amputated, 27 limbs salvaged).
Of these 27 salvaged limbs, 22 had healed ulcers and relief
of rest pain. Remaining five had minimal residual lesions, but
were ambulatory. On life table analysis 1-, 3-, and 5-year
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cumulative primary patency rates were 66% (95% CI, 60.6-
72.8), 59% (95% CI, 52.1-66.1), and 58% (95% CI, 50.9-
65.0) and secondary patency rates were 78% (95% CI,
72.7-83.5), 72% (95% CI, 65.4-78.5), and 71% (95% CI,
64.1-77.7), respectively (Fig 2).
Limb salvage. There were 42 late amputations.
Thirty-five limbs were lost after graft occlusion (12%), and
16 (6%) were lost despite patent grafts for an overall
amputation rate of 18%. All 16 amputations with patent
grafts were for ongoing foot infection and osteomyelitis;
ESRD was a contributory factor in five patients.
Cumulative limb salvage rates at 1, 3, and 5 years were
85% (95% CI, 80.3-89.5), 79% (95% CI, 73.9-85.1), and
78% (95% CI, 71.7-83.7), respectively (Fig 2).
Adjunctive procedures. A total of 138 adjunctive
operative procedures were performed in 97 limbs during
the follow-up period (Table V).
Outcome
At last follow-up or death, 65% (146) of ischemic
ulcers/gangrenous wounds were healed, and another five
healed and recurred, two of which were nearly healed
again. A total of 219 (78%) of 280 operated limbs had a
functional foot used for ambulation or transfer. Overall,
143 patients were alive with 161 salvaged feet at last fol-
low-up. On life table analysis, 1-, 3-, and 5-year cumula-
tive rates of patients alive with a salvaged limb were 75%
(95% CI, 70.0-81.1), 61% (95% CI, 54.5-68.3), and 48%
(95% CI, 40.5-56.4), respectively. At last follow-up, 150
patients were alive with a patent graft. Of these, 139 limbs
were salvaged, and 135 were being used for ambulation.
These results were achieved at the expense of adjunctive
procedures in 160 limbs (57.1%); 85 limbs (30.4%) under-
went two or more adjunctive procedures (Fig 4).
Table IV. Complications
No. (%)
Early complications (within 30 d)
Mortality* 4 (1.6)
Myocardial infarction 18 (6.4)
Renal insufficiency 6 (2.1)
Stroke 2 (0.7)
Deep venous thrombosis 2 (0.7)
Hematoma 18 (6.4)
Wound infection 17 (6.1)
Late complications
Mortality* 76 (30.1)
Myocardial infarction 13 (4.7)
Wound infection 23 (8.4)
Graft infection 1 (0.4)
Graft occlusion 59 (21.5)
Graft stenosis 23 (8.4)
*Mortality was assessed in 256 patients and includes three deaths within 30
days and a fourth on day 40 during the same hospitalization.
Table V. Adjunctive procedures after 280 pedal bypass
grafts
No. of limbs (%)
Within 30 d 97 (34.6)
Wound debridement 49 (17.5)
Minor amputation 37 (13.2)
Graft thrombectomy 10 (3.6)
Graft revision 9 (3.2)
Hematoma evacuation 8 (2.9)
Myocutaneous flap 8 (2.9)
Skin grafting 7 (2.5)
Major amputation 9 (3.2)
Inflow procedure 3 (1.1)
During follow-up 97 (34.6)
Major amputation 42 (15.0)
Minor amputation 34 (12.4)
Wound debridement 27 (9.6)
Graft revision 23 (8.2)
Graft thrombectomy 8 (2.9)
Inflow procedure 1 (0.4)
New graft 1 (0.4)
Skin grafting 1 (0.4)
Sympathectomy 1 (0.4)
Risk factor analysis
Univariate analysis identified composite vein graft and
secondary revascularization as factors associated with poor
primary patency (P < .001, P = .024, respectively).
Composite vein graft was associated with poor secondary
patency (P = .009) and with limb loss (P < .001) (Table VI,
Fig 5). Intraoperative graft blood flow of 50 mL/min or
more and presence of diabetes were associated with improved
primary (P = .001, P = .024, respectively) and secondary
patency (P = .003, P < .001, respectively), but not limb sal-
vage (P = .075, P = .461, respectively) (Table VI, Fig 6).
Renal insufficiency was associated with worse limb salvage (P
= .048). ESRD was associated with significantly worse limb
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salvage (P < .001) and patient survival (P = .011) (Table VI,
Fig 7). A higher age at surgery correlated with worse long-
term survival (P = .0001). With the dichotomization of age
at 60 years, older age correlated with worse survival (5-year
survival 56% vs 77%, P = .015). Factors significant on multi-
variate analysis are listed in Table VII.
DISCUSSION
Pedal bypass grafting with autologous vein is safe,
effective, and durable as demonstrated by this and several
previously published studies.11,12 However, the decision
between revascularization and primary amputation in
elderly patients with multiple comorbidities and limited life
expectancy is still a challenging and soul-searching exercise.
Fig 2. Cumulative graft patency, limb salvage, and patient sur-
vival after 280 pedal bypass grafts in 256 patients. SEM < 10% for
all time points.
Fig 3. Cumulative survival rates in 50 patients subsequent to
amputation after pedal bypass grafting compared with expected
survival in an age- and sex-matched cohort. Dotted line represents
SEM > 10%.
Fig 4. Incidence of adjunctive procedures in 280 limbs after pedal
bypass grafting.
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Table VI. Association of clinical variables with 5-year cumulative patency, limb salvage, and survival
Primary patency Secondary patency Limb Survival
Risk factor No. of pts. (%) P value (%) P value (%) P value (%) P value
Patient-related factors
Sex
Male 174 60 .177 72 .082 78 .796 56 .37
Female 82 53 66 76 67
Age, > 80 y
No 225 58 .823 70 .322 77 .356 65 < .001
Yes 31 56 78 85 24
Diabetes
No 65 54 .024 55 < .001 77 .461 50 .057
Yes 191 59 75 80 64
Smoking
No 106 55 .386 72 .987 77 .965 59 .889
Yes 150 60 69 78 61
Renal insufficiency
No 219 58 .425 72 .147 81 .048 64 .147
Yes 37 50 65 74 40
ESRD
No 237 58 .168 71 .223 80 < .001 62 .011
Yes 23 52 70 41 27
Coronary disease
No 124 56 .578 72 .579 80 .419 64 .177
Yes 132 59 69 75 55
Cerebrovascular disease
No 202 56 .515 69 .601 77 .855 65 .05
Yes 54 64 77 82 42
Primary patency Secondary patency Limb salvage Survival
Risk factor No. of limbs (%) P value (%) P value (%) P value (%) P value
Limb-related factors
Chronic ischemia
Category 4 29 50 .655 51 .272 67 .75 63 .673
Category 5 251 59 73 79 60
TcO2
> 20 mm Hg 27 79 .22 78 .582 84 .909 77 .179
< 20 mm Hg 224 54 69 75 58
Secondary revascularization
No 257 59 .024 72 .062 77 .956 57 .296
Yes 23 43 56 82 79
Vein used
Single-length 235 62 < .001 73 .009 81 < .001 60 .762
Composite 45 25 63 58 64
Graft length
Short graft 150 62 .323 70 .897 80 .592 63 .208
Long graft 130 53 71 75 58
DP anastomosis
No 87 58 .751 69 .652 76 .608 69 .065
Yes 193 50 72 78 56
Flow rate 
≥ 50 mL/min 87 66 .001 78 .003 81 .075 58 .35
< 50 mL/min 193 39 53 68 68
Runoff score*
1 37 74 79 91 60
2 40 50 .268 66 .636 67 .317 65 .315
3 22 60 64 76 73
Renal insufficiency: serum creatinine level > 2 mg/dL.
*Runoff score available only in first 100 patients: 1 = patent pedal arch, 2 = incomplete pedal arch, 3 = little or no pedal arch.
DP, dorsalis pedis artery; ESRD, end-stage renal disease; TcO2, transcutaneous oxygen tension. 
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This retrospective analysis was undertaken to test our
aggressive policy of attempting revascularization in all
patients capable of ambulation or transfer, with the excep-
tion of patients with wet gangrene associated with sepsis.
We previously reported our results in terms of graft patency
and limb salvage, which compared favorably with other
reported series.13,22 Justification of aggressive revascular-
ization requires assessment of other meaningful measures
of outcome, such as long-term morbidity and mortality
and functional status. An important consideration is the
escalation in treatment costs in patients requiring multiple
additional procedures for limb salvage and in those with
failed reconstruction leading to amputation.23,24
The results of this series with a secondary patency rate
of 71% and limb salvage rate of 78% at 5 years compare
favorably with the reported literature (41%-84% and 54%-
89%, respectively).12,24-26 Diabetic patients fared signifi-
cantly better in terms of primary and secondary graft
patency although limb salvage was not significantly differ-
ent from nondiabetic patients (80% vs 77%). The disease
pattern in diabetic patients with atherosclerosis of the
infrageniculate arteries and relative sparing of the pedal
vessels27 lends itself to successful pedal bypass grafting,
with limb loss often occurring because of uncontrolled
sepsis. The safety of distal bypass grafting in diabetic
patients has been demonstrated by other authors, also.7,12
Unlike other reports,28,29 our series failed to confirm
poorer long-term survival in diabetic patients with critical
limb ischemia compared with nondiabetic patients. Akbari
et al7 also recently reported similar long-term survival in
diabetic and nondiabetic patients after lower extremity
revascularization.
On the other hand, patients with ESRD fared signifi-
cantly worse in all respects, limb salvage and patient sur-
vival. Revascularization in these patients remains
controversial with dismal results reported by several
authors.16,30,31 Patients with a renal transplant fared
slightly better (limb loss, 1/4) than those undergoing
dialysis (limb loss, 7/17), although the numbers are too
small to make any firm conclusions. Our results would
imply that patients with ESRD who require composite
vein grafts may not merit an attempt at limb salvage; of six
such patients, four limbs were lost by 7 months.
Octogenarians fared well in our hands with no differ-
ence in graft patency or limb salvage compared with their
younger counterparts. Long-term patient survival was,
however, worse in these elderly patients. Limb salvage
rates in octogenarians were comparable to younger
patients in other series as well, with satisfactory functional
results at the cost of a modest increase in operative mor-
tality (2.2 vs 6.7%).8,32,33 However, the mortality rate
after primary amputation is also higher in this age group
Fig 5. Cumulative graft patency, limb salvage, and patient survival after 45 pedal bypass grafts performed with composite vein in 41
patients compared with 235 bypass grafts performed with single-length vein in 215 patients. Dotted line represents SEM > 10%.
(9.8% vs 14.7%), with a considerably decreased chance of
rehabilitation after amputation.34-36
Poor graft patency and limb salvage in limbs with
composite vein grafts are disconcerting in our series and in
others,37,38 though not surprising. However, these results
are still superior to those obtained with prosthetic grafts,
and their use seems justified.39
Does failed revascularization result in a higher level of
amputation? This question remains unanswered with sev-
eral reports in the literature on either side of the argu-
ment.40-42 In this study seven of 51 above-knee, 44
below-knee, and one Syme’s amputations were performed.
Presuming that all limbs would have been suitable for pri-
mary below-knee amputation before an attempt at revascu-
larization preservation of the knee in 88% of secondary
amputees is in concordance with the successful healing rate
of primary below-knee amputations (85%-92%).40,41 The
cumulative probability at 5 years of having a below-knee
amputation was not significantly different in diabetic
patients compared with nondiabetic patients (21% vs 17%),
nor was the probability of an above-knee amputation (2%
vs 6%). Therefore, our data do not support the view that
initial bypass grafting raises the level of amputation.
The most compelling finding of this study is that
patients with failed revascularization and resultant ampu-
tation had worse long-term survival compared with the
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entire patient cohort. Amputation was a significant inde-
pendent risk factor, predicting higher long-term mortality
on multivariate analysis. Panayiotopoulos et al42 reported
better survival in 70 patients with successful femoro-
crural/pedal grafts compared with 82 amputees (62% vs
39% at 3 years), which included both primary and sec-
ondary amputations. Equivalent long-term survival rates
have been reported in patients undergoing amputation
after failed revascularization and in those undergoing pri-
mary amputation (37% and 30% at 3 years, respectively).42
We did not do a similar comparative analysis because
patients at our institution undergoing primary amputation
are a different cohort with no scope for revascularization
or ultimate ambulation. Five-year overall survival was sig-
nificantly less than an age- and sex-matched cohort (60%
vs 87%). Still, survival in our series was higher than in sev-
eral other reports.17,24,26,29
Disappointing functional results have been observed
after infrainguinal revascularization with only 45% of
patients reporting feeling “back to normal” at 6 months
and 54% requiring repeat operations.43,44 Only 14% of
patients undergoing infrainguinal revascularization
achieved the ideal surgical results in one study, with no
complications, long-term symptom relief, maintenance of
functional status, and no repeat operations.45 On assess-
ment of residential and ambulatory status together at 1
Fig 6. Cumulative graft patency, limb salvage, and patient survival after 210 pedal bypass grafts in 191 diabetic patients compared with
70 bypass grafts in 65 nondiabetic patients. SEM < 10% for all time points.
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year, Pomposelli et al8 reported an improvement in 78%
and maintenance in 88% of patients. They and other
authors identified preoperative baseline functional status
as a predictor of good functional outcome after revascu-
larization.43,46 In our series, 78% of limbs were used for
ambulation at last follow-up or death.
Few studies have dealt with improvement in health-
related quality of life after revascularization.47,48 Successful
outcome after pedal bypass grafting is often at the cost and
morbidity of repeated interventions to salvage the graft and
limb. Nearly one third of patients in our series had two or
more adjunctive procedures. Late reinterventions are com-
mon after infrainguinal revascularizations.45 Dawson and
van Bockel44 reported a cumulative reintervention rate of
25% at 1 year and 40% at 5 years. The costs of uncompli-
cated bypass graft surgery and primary amputation have
been reported to be comparable when costs of the pros-
thesis and rehabilitation after amputation are included.23,24
Raviola et al23 reported escalation in cost of revasculariza-
tion from $20,300 to $42,200 in patients requiring rein-
terventions, but also reported an equivalent increase in cost
in the event of complications after primary amputation,
from $20,400 to $40,600. Several reports have confirmed
better functional results after revascularization.8,35
A drawback of our analysis is the lack of cost data to
justify our policy of stretching the limits of limb revascu-
larization to include every patient with hope of eventual
ambulation. In view of improved survival after successful
pedal bypass grafting demonstrated by this study, a
prospective evaluation of cost per quality life-year added is
warranted. It remains to be emphasized that ethical con-
siderations far outweigh cost considerations in any indi-
Fig 7. Cumulative graft patency, limb salvage, and patient survival after 23 pedal bypass grafts in 19 patients with ESRD compared with
257 bypass grafts in 237 patients without ESRD. Dotted line represents SEM > 10%.
Table VII. Multivariate analysis of risk factors affecting
outcome
Odds 95% 95% P
Variable ratio CI lower CI upper value
Primary patency
Diabetes 0.59 0.378 0.919 .0196
Flow ≥ 50 mL/min 0.551 0.362 0.837 .0052
Composite vein 2.131 1.313 3.459 .0022
Secondary patency
Diabetes 0.39 0.235 0.65 .0003
Flow ≥ 50 mL/min 0.504 0.302 0.842 .0089
Composite vein 1.908 1.034 3.521 .0389
Limb salvage
ESRD 3.895 1.873 8.102 .0003
Composite vein 2.616 1.421 4.815 .002
Patient survival
ESRD 5.78 2.408 13.874 .0001
Amputation 2.033 1.151 3.588 .0144
Age 1.068 1.041 1.096 .0001
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vidual patient when deciding between revascularization
and primary amputation.
We conclude that our results justify attempting distal
bypass grafting to the foot vessels, even in high-risk patients.
Revascularization with pedal bypass grafting results in good
long-term limb salvage and functional ability for ambula-
tion. Successful pedal bypass grafting is associated with
improved long-term survival compared with survival in
patients undergoing amputation. These results are, how-
ever, achieved at the cost of multiple interventions in more
than half the patients, and the impact of this on health care
costs needs to be assessed. Caution is recommended when
offering distal reconstruction to patients with ESRD.
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DISCUSSION
Dr Frank W. LoGerfo (Boston, Mass). I want to compliment
you on this excellent work, Dr Kalra. You have described your
several target vessels, several inflow vessels, and several types of
techniques in handling the conduit and bringing home the tech-
nical expertise that it takes to be successful in pedal bypass and
how important it is in our training programs that we convey this
information to our trainees. You may want to comment on how
you accomplish this in your own program in terms of your
trainees and your thoughts about their ability to carry on this
work at the time of the completion of your program. It really can
make a difference for patients.
Do you use angioscopy in preparation of the conduit? Can
you comment on the mechanism of failure of the grafts that fail?
What is the source of failure, and do you do graft surveillance?
Dr Manju Kalra. Thank you, Dr LoGerfo for your kind com-
ments. Coming to your first question, all of these bypasses were
performed by one of three consultant vascular surgeons together
with a vascular fellow or general surgery chief resident. So trainees
at our institution get an adequate exposure and opportunity to
learn the techniques involved, and our vascular fellows are quite
capable of carrying on this work in their future careers.
To answer your second question, we do not use angioscopy
in preparation of the venous conduit. We have used a Mills valvu-
lotome in most of our patients and cut the valves in the vein graft
under direct vision.
As far as the mechanism of graft failure is concerned, the causes
responsible for early graft failure were different from those seen in
late failures. Early failure occurred in 19 grafts, and causes included
technical problems, external compression of the graft by tense skin
or tendon of the external hallucis longus muscle, and poor distal
runoff. The most frequent cause of late failure was, of course, inti-
mal hyperplasia in the vein graft and at the distal anastomosis.
Graft surveillance has been performed by duplex ultrasound
at our institution since December 1989. The surveillance proto-
col has evolved during the study and now includes an examina-
tion before discharge from the hospital, a return visit at 6 weeks,
and every 6 months thereafter.
Dr Frank B. Pomposelli (Boston, Mass). I, too, rise to com-
pliment you on a truly excellent result with this operation. We’ve
had a long-standing interest in this procedure as well. 
I’m curious about your patients with end-stage renal disease
and dialysis. We struggle with this group of patients as well. Did
you have any patients in that group who had amputations with
patent grafts? And are there any patients in that group or subset
in whom you think an attempt at limb salvage is not appropriate? 
Dr Kalra. Yes, the patients with end-stage renal disease do
worry us, too, and that is why we presented them as a specific
subgroup. In 19 such patients with 23 pedal grafts, nine amputa-
tions were performed. Six of these (66%) were done in the pres-
ence of patent grafts. The two risk factors that stood out on
multivariate analysis for poor limb salvage were end-stage renal
disease and composite vein graft. Of six patients who had both of
these risk factors, we lost four limbs within 7 months. So, we
agree with your group that we need to be realistic and cautious
when we offer revascularization to this group of patients. 
Dr James M. Seeger (Gainesville, Fla). Just a quick follow-
up on that same thought process, in that you’ve identified a
group of patients who clearly don’t benefit, or benefit fairly
poorly, and who, despite a successful graft, go on to amputa-
tion and then a high mortality. Are there any other factors,
other than the fact they didn’t have enough vein and had end-
stage renal disease, that allowed you to identify those people
preoperatively? Because in that group of patients, you’re prob-
ably not benefiting them very well. 
Dr Kalra. We looked at cardiovascular risk factors, the degree
of ischemia, TcPO2 levels in the foot, completeness of the pedal
arch, and none of these factors were independent predictors of
limb loss on multivariate analysis.
